A team of Boston College researchers report in the journal Nature Nanotechnology that a cluster of carbon nanotubes coated with a thin layer of protein-recognizing polymer form a biosensor capable of using electrochemical signals to detect minute amounts of proteins, which could provide a crucial new diagnostic tool for the detection of a range of illnesses.
The nanotube biosensor proved capable of detecting human ferritin, the primary iron-storing protein of cells, and E7 oncoprotein derived from human papillomavirus. Further tests using calmodulin showed the sensor could discriminate between varieties of the protein that take different shapes, according to the multi-disciplinary team of biologists, chemists and physicists.
Problems Linked to Chemo Could be Solved by Nanotechnology
A nanotechnology approach that potentially could eliminate the problems of side effects and drug resistance in the treatment of cancer has been developed by scientists.
Advertisement
Molecular imprinting techniques have shown that polymer structures can be used in the development of sensors capable of recognizing certain organic compounds, but recognizing proteins has presented a difficult set of challenges. The BC team used arrays of wire-like nanotubes - approximately one 300th the size of a human hair - coated with a non-conducting polymer coating capable of recognizing proteins with subpicogram per liter sensitivity.
Central to the function of the sensor are imprints of the protein molecules within the non-conducting polymer coating. Because the imprints reduce the thickness of the coating, these regions of the polymer register a lower level of impedance than the rest of the polymer insulator when contacted by the charges inherent to the proteins and an ionized saline solution. When a protein molecule drops into its mirror image, it fills the void in the insulator, allowing the nanotubes to register a corresponding change in impedance, signaling the presence of the protein, according to co-author Dong Cai, an associate research professor of Biology at BC.
![Tiny Implantable Device for Drug Delivery Developed Using Nanotechnology-Magnetism Combination]( "Tiny Implantable Device for Drug Delivery Developed Using Nanotechnology-Magnetism Combination")
Researchers have developed a small implantable device that can be repeatedly turned on and off to deliver and adjust doses of medications inside a patient's body
The detection can be read in real time, instead of after days or weeks of laboratory analysis, meaning the nanotube molecular imprinting technique could pave the way for biosensors capable of detecting human papillomavirus or other viruses weeks sooner than available diagnostic techniques currently allow. As opposed to searching for the HPV antibody or cell-mediated immine responses after initial infection, the nanotube sensor can track the HPV protein directly. In addition, no chemical marker is required by the lebel-free electrochemical detection methods.
"In the case of some diseases, no one can be sure why someone is ill," said Cai. "All that may be known is that it might be a virus. At that time, the patient may not have detectable serum antibodies. So at a time when it is critical to obtain a diagnosis, there may not be any traces of the virus. You've basically lost your chance. Now we can detect surface proteins of the virus itself through molecular imprinting and do the analysis."
Source: Eurekalert
Tiny Implantable Device for Drug Delivery Developed Using Nanotechnology-Magnetism Combination
Researchers have developed a small implantable device that can be repeatedly turned on and off to deliver and adjust doses of medications inside a patient's body
Advertisement
The detection can be read in real time, instead of after days or weeks of laboratory analysis, meaning the nanotube molecular imprinting technique could pave the way for biosensors capable of detecting human papillomavirus or other viruses weeks sooner than available diagnostic techniques currently allow. As opposed to searching for the HPV antibody or cell-mediated immine responses after initial infection, the nanotube sensor can track the HPV protein directly. In addition, no chemical marker is required by the lebel-free electrochemical detection methods.
"In the case of some diseases, no one can be sure why someone is ill," said Cai. "All that may be known is that it might be a virus. At that time, the patient may not have detectable serum antibodies. So at a time when it is critical to obtain a diagnosis, there may not be any traces of the virus. You've basically lost your chance. Now we can detect surface proteins of the virus itself through molecular imprinting and do the analysis."
Source: Eurekalert
How to Assess Risks of Nanotechnology and Offer Protection
Canadian engineers suggest that research is needed into the risks associated with the growing field of nanotechnology manufacture
Advertisement
NanoPen - New Kid on the Nanotechnology Block For Better Medical DiagnosisA team of scientists in California have announced the creation of a 'NanoPen' that can simplify the method of laying down patterns of nanoparticles-from wires to circuits-for making | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
Scientists identified mechanisms governing immune cells, selectively removing troublemakers to reshape skin immunity. Benefits those with psoriasis, vitiligo.
By 2050, an anticipated increase from 494 million cases in 2020 to 1.06 billion people with musculoskeletal disabilities is expected.
Experts consulted by GlobalData anticipate a significant overhaul in the Gaucher disease scenario because of forthcoming gene therapies in development.
Within the seven major markets, 12% to 20% of diagnosed prevalent NASH cases present severe liver damage (stage 4 liver fibrosis), denoting cirrhosis.
Memory deficits in individuals with epilepsy, especially cognitive difficulties, might partially stem from the transient impairments caused by these slow waves.